Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10779914 | 0.82 | — | — | |
| SCHEMBL81512 | 0.75 | NPC1 (0.32) | KMT2A | |
| SCHEMBL2117963 | 0.73 | — | — | |
| SCHEMBL10907064 | 0.71 | ALDH1A1 (0.53) | — | |
| SCHEMBL2116123 | 0.69 | — | — | |
| SCHEMBL2115243 | 0.67 | HRH3 (0.32) | — | |
| SCHEMBL2117543 | 0.67 | — | — | |
| SCHEMBL2118363 | 0.67 | CYP1A2 (0.36) | KMT2A | |
| SCHEMBL2117199 | 0.67 | KDM4E (0.32) | — | |
| SCHEMBL218726 | 0.65 | ALDH1A1 (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101646657-B | Process for producing trichloropyrimidine compound | SUMITOMO CHEMICAL CO JP | 2012-08-08 | — | — | CN | disclosed |
| US-8158787-B2 | Process for producing trichloropyrimidine compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-04-17 | — | — | US | disclosed |
| US-20100160630-A1 | PROCESS FOR PRODUCING TRICHLOROPYRIMIDINE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-24 | — | — | US | disclosed |
| EP-2128141-A1 | PROCESS FOR PRODUCING TRICHLOROPYRIMIDINE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2009-12-02 | — | — | EP | disclosed |
| EP-1296957-A2 | SYNTHESIS OF CHLORINATED PYRIMIDINES | Syngenta Limited (GB) | 2003-04-02 | — | — | EP | disclosed |
| US-20020042514-A1 | Synthesis of chlorinated pyrimidines | SYNGENTA LIMITED (GB) | 2002-04-11 | — | — | US | disclosed |
| WO-2002000628-A2 | SYNTHESIS OF CHLORINATED PYRIMIDINES | SYNGENTA LIMITED (GB) | 2002-01-03 | — | — | WO | disclosed |
| US-6160117-A | Chemical process | ZENECA LIMITED (GB) | 2000-12-12 | — | — | US | disclosed |
| EP-0125650-B1 | REACTIVE DYES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE DYEING AND PRINTING OF SUBSTRATES | BAYER AG (DE) | 1987-04-01 | — | — | EP | disclosed |
| EP-0125650-A2 | Reactive dyes, process for their preparation and their use in the dyeing and printing of substrates | BAYER AG (DE) | 1984-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020042514-A1 | Synthesis of chlorinated pyrimidines | DPYD, TYMP, TYMS | KMT2A 1160/4885 |
| US-20100160630-A1 | PROCESS FOR PRODUCING TRICHLOROPYRIMIDINE COMPOUND | DPYD, TYMP, TST | KMT2A 3104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.